Pacific Biosciences of California, Inc. (PACB) Operating income 2016–2025
Pacific Biosciences of California, Inc. (PACB) annual operating income history from SEC filings — each fiscal year as reported.
-$553.9MFY2025 · since FY2016: -$71.2M → -$553.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$553.9M | -16.8% |
| FY2024 | -$474.3M | -41.8% |
| FY2023 | -$334.5M | -8.9% |
| FY2022 | -$307.2M | -46.0% |
| FY2021 | -$210.4M | -101.6% |
| FY2020 | -$104.4M | -3.8% |
| FY2019 | -$100.5M | +0.4% |
| FY2018 | -$101.0M | -12.5% |
| FY2017 | -$89.8M | -26.0% |
| FY2016 | -$71.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice